Drawing for AMPLY

USPTO serial 97354377

AMPLY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
STERLIN, DEBORAH L
Law office
TMO LAW OFFICE 126- EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AMPLY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rita E. Kline

Rita E. Kline RENNER, OTTO, BOISSELLE & SKLAR, LLP1621 EUCLID AVENUEFLOOR 19CLEVELAND, OH 44115

Goods and services

ClassDescriptionStatusFirst use
009Computer software; artificial intelligence software in the field of pharmaceuticals and biopharmaceuticalsACTIVE—
042Scientific and technological research in the field of pharmaceuticals and biopharmaceuticals; Pharmaceutical and biopharmaceutical drug development services; design and development of software platforms in the field of pharmaceuticals and biopharmaceuticals; research in the field of artificial intelligence technology; providing artificial intelligence computer programmes on data networks; data mining softwareACTIVE—
044Medical services; pharmaceutical and biopharmaceutical services; consultancy and information services relating to pharmaceutical and biopharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 18, 2023MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 18, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 18, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 31, 2023GRMLCORRESPONDENCE E-MAILED—
Jan 31, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2023AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jan 31, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 25, 2023DOCKASSIGNED TO EXAMINER—
Apr 13, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 12, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance